Brind.

Ligand Pharmaceuticals formed drug development partnerships with Amgen, Merck KGaA, and Pfizer.

2 reports, 2 independent Updated Sep 19
Gone quiet
Reports
2
Developments
3
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Ligand Pharmaceuticals formed drug development partnerships with Amgen, Merck KGaA, and Pfizer.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Ligand Pharmaceuticals funds drug development in partnership with Merck.Sub-event
  2. Ligand Pharmaceuticals appointed Todd Davis as CEO, acquired a 56% stake in Pelthos Therapeutics Inc., and secured royalty rights on ZELSUVMI sales.Sub-event
  3. Ligand announced new drug development partnerships with three major pharmaceutical companies.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • dailypolitical.com
  • GlobeNewswireLigand to Report Second Quarter 2025 Financial Results on August 7, 2025 JUPITER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it wi